IRIS PubliCatt

Rossi, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.207
EU - Europa 1.973
AS - Asia 611
AF - Africa 22
SA - Sud America 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.194
DE - Germania 576
SE - Svezia 410
IT - Italia 338
CN - Cina 259
SG - Singapore 198
UA - Ucraina 133
IE - Irlanda 117
FR - Francia 101
PL - Polonia 89
ID - Indonesia 72
GB - Regno Unito 59
RU - Federazione Russa 53
FI - Finlandia 36
IN - India 29
CI - Costa d'Avorio 15
BE - Belgio 13
AT - Austria 12
CA - Canada 10
IR - Iran 10
AU - Australia 9
TR - Turchia 9
BR - Brasile 6
CH - Svizzera 5
ES - Italia 5
JP - Giappone 5
KR - Corea 5
LT - Lituania 4
NL - Olanda 4
RO - Romania 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DZ - Algeria 3
HK - Hong Kong 3
IQ - Iraq 3
MY - Malesia 3
TH - Thailandia 3
VN - Vietnam 3
CL - Cile 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
KZ - Kazakistan 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
KH - Cambogia 1
LI - Liechtenstein 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.841
Salva come PNG Salva come JPEG
Città #
Chandler 474
Ashburn 210
Singapore 154
Dublin 114
Wilmington 91
San Mateo 85
Jacksonville 81
Fairfield 79
Warsaw 74
Jakarta 71
Ann Arbor 65
Milan 60
Nanjing 60
Dearborn 59
Cattolica 58
Rome 57
Woodbridge 56
Houston 53
New York 53
Boston 49
Marseille 39
Seattle 39
Princeton 38
Moscow 37
Redwood City 32
Munich 28
Lawrence 25
Los Angeles 25
Nürnberg 25
Beijing 24
Detroit 23
Redmond 23
Nanchang 22
Chicago 21
Cambridge 20
Bologna 18
Hangzhou 18
Hebei 17
Abidjan 15
Kraków 15
Boardman 14
Norwalk 14
Brussels 13
Leawood 13
Washington 13
Changsha 10
Tianjin 10
Bremen 9
Florence 9
Mountain View 9
San Diego 9
Toronto 9
London 8
Helsinki 7
Kunming 7
Pune 7
Busto Arsizio 6
University Park 6
Vienna 6
Guangzhou 5
Izmir 5
Jiaxing 5
Lancaster 5
Perugia 5
Reston 5
Shenyang 5
Simi Valley 5
Andover 4
Clearwater 4
Fremont 4
Glendale 4
Hefei 4
Hounslow 4
Paris 4
Peterborough 4
São Paulo 4
Vladivostok 4
Zhengzhou 4
Baotou 3
Bolzano 3
Busan 3
Cape Town 3
Changchun 3
Dong Ket 3
Hong Kong 3
Jinan 3
Sacramento 3
San Francisco 3
Southend 3
Algiers 2
Almaty 2
Amsterdam 2
Bagnacavallo 2
Bagnoli Irpino 2
Bern 2
Budapest 2
Buenos Aires 2
Canberra 2
Chester Springs 2
Essen 2
Totale 2.825
Salva come PNG Salva come JPEG
Nome #
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 267
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 260
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 192
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 171
Risk factor and etiology analysis of ischemic stroke in young adult patients 142
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 119
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 115
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 109
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 107
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 105
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 103
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 103
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 96
Venous thromboembolism in multiple myeloma 94
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 92
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 92
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 90
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 79
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 78
Inherited thrombophilia: treatment during pregnancy. 77
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 74
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 71
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 71
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 71
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 69
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 68
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 66
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 66
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 65
Assessment of congenital neutropenia in children: common clinical sceneries and clues for management 65
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 63
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 63
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 57
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 56
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 56
Structural analysis of protein Z gene variants in patients with foetal losses 53
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 53
Venous thromboembolism in patients with liver diseases 52
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 48
Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia 47
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 46
Cerebral sinus-venous thrombosis 45
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 45
Venous thromboembolism in patients with liver diseases 43
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 43
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases 42
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 41
Second cancers in MPN: Survival analysis from an international study 41
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? 40
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 40
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 39
Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study 36
Reassessment of contractile reserve after revascularization of akinetic myocardium 36
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: An expert consensus 35
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms 34
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 34
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 29
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 29
Glycoprotein la C807T qene polymorphism and increased risk of recurrent acute coronary syndromes: A five year follow up 29
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases 27
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 25
Left atrial myxoma supplied from the right coronary artery 17
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 14
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 12
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 11
Risk factor and etiology analysis of ischemic stroke in young adult patients 10
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 10
Glycoprotein IA C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. 8
Coagulopathy in CAR-T: Critical concern or mere blip? 6
Totale 4.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.755
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020351 0 0 0 0 44 74 41 15 39 32 63 43
2020/2021467 26 42 20 55 48 37 50 22 54 25 75 13
2021/2022659 46 34 16 39 31 12 20 80 45 45 118 173
2022/20231.331 198 194 114 197 74 155 79 82 151 25 33 29
2023/2024719 28 170 30 51 33 120 36 39 14 31 77 90
2024/2025338 26 67 89 59 97 0 0 0 0 0 0 0
Totale 4.960